HIF-1 complex inhibitors (Cell Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameHIF-1 complex inhibitors (Cell Therapeutics)
Drug Alias NameHIF-1 complex inhibitors (Novuspharma)anti-angiogenic compounds (Novuspharma)anti-angiogenic compounds (Novuspharma/Prolifix)NPH-006052NPH-005891
ClassificationSmall molecules
Mechanisms of ActionAngiogenesis inhibitorsVascular endothelial growth factor receptor antagonistsAnticancer protein kinase inhibitors
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTopoTarget UK Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovuspharma SpATopoTarget UK LtdCti Biopharma Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A